DR.D.KANUNGO
ADDITIONAL DIRECTOR GENERAL(Rtd.)
Ministry of Health and FW
DR.D.KANUNGO ADDITIONAL DIRECTOR GENERAL(Rtd.) Ministry of Health - - PowerPoint PPT Presentation
DR.D.KANUNGO ADDITIONAL DIRECTOR GENERAL(Rtd.) Ministry of Health and FW & Chairperson Scientific Panel on Pesticide and Antibiotic Residues FSSAI UNDERSTANDING GLOBAL PRACTICES IN RISK ANALYSIS OF CHEMICAL CONTAMINANTS Geeta
ADDITIONAL DIRECTOR GENERAL(Rtd.)
Ministry of Health and FW
Srimad Bhagwat Geeta Chapter 17 Verse-10
The Food and Agriculture Organization of the United Nations (FAO) and World Health Organization (WHO) have a long history of collaboration in the Safety Evaluation of Chemicals in food. This activity began in 1956, when the first meeting
Additives (JECFA) was convened by the two
1960s
General Subject Committees
Codex Committee on Contaminants in Foods
Codex Committee on Food Additives
Codex Committee on Food Hygiene
Codex Committee on Food Import and Export Inspection and Certification Systems
Codex Committee on Food Labelling
Codex Committee on General Principles
and Sampling
for Special Dietary Uses
Codex Committee on Pesticide Residues
Veterinary Drugs in Foods
Commodity Committees
Cereals, Pulses and Legumes
Fresh Fruits and Vegetables
and Oils
Processed Fruits and Vegetables
Spices and Culinary Herbs
Food Additives
Residues
Microbiological Risk Assessment
❖ Environmental pollutants, such as
❖ Mycotoxins, ❖ Migrants from packaging materials ❖ Other substances not authorized for use in food. ❖ EMRL Food contaminants are generally unavoidable
AGENDA
FAO /WHO
JECFA SECRETARIATE May add on its own PRIORITY LIST CCCF
MEMBER STATES
Earlier meetings of JECFA.
data.-LOQ
have impurity of contaminants
(FAO/WHO, 2008):
Risk Assessment
Risk Management
Risk Communication
information and opinions concerning risks
harm will occur as a result of exposure to specific hazards.
– IDENTIFY REAL OR POTENTIAL HAZARD – DETERMINE PROBABILITY OF IT HAPPENING – ASSESS SEVERITY ON HEALTH, ENVIRONMENT, ECONOMY, OR SOCIAL IMPACT
component of risk analysis
scientific uncertainty.
associated risks to life and health resulting from exposure of humans to chemicals present in food over a specified period.
situation having the potential to cause adverse effects when an organism, system or (sub)population is exposed to that agent.
an organism, system or (sub)population caused under specified circumstances by exposure to an agent. (WHO/IPCS,2004)
DK 21
Hazard identification Hazard characterization Exposure assessment Risk characterization
Step 1 - Hazard Identification Examines whether a substance has the potential to cause harm to humans and/or ecological systems, and if so, under what circumstances. Step 2 - Dose Response Assessment Examines the numerical relationship between exposure and effects. .
Hazard Identification Hazard characterization Exposure assessment Risk characterization
Is there a problem? How do you know?
Purpose
health effects, based on assessment of all available data on toxicity and mode of action. Designed to primarily address two questions:
agent may pose and
hazard may be expressed.
cells or tissue preparations from laboratory animals or humans; - reduced, refined or replaced But No Guidance value
humans.
and toxicokinetics)
depends on the nature and use of the substance under consideration.
conclusion on the risk assessment for a particular substance.
screening tests or a limited number of standard toxicity studies are conducted, which may be sufficient for risk assessment or may trigger necessary further investigations.
findings and interpretation of the results are the most important steps in risk assessment
the hazard characterization within the risk assessment paradigm.
risk assessment advice and to derive health- based guidance values.
Dose-response Assessment and Endpoint Selection : Definitions
Endpoint : Toxic Effect upon which the risk assessment is based Lowest Observed Adverse Effect Level (LOAEL): Lowest dose from a study at which adverse toxic effects were observed No Observed Adverse Effects Level (NOAEL): The dose below the LOAEL at which no adverse toxic effects are observed Point of Departure (POD): Any dose level used to quantify risk (generic)
NOAEL / LOAEL Dose Spacing
NOAEL / LOAEL dose spacing usually ranges between 2X and 10X. True NOAEL will be somewhere between the NOAEL and LOAEL Will always lead to a conservative (protective) hazard estimate
Dose-response Assessment and Endpoint Selection Endpoints selected for risk assessment must be the most sensitive endpoint for each population, and relevant to humans. Most sensitive (protective) Most protective POD Relevant Toxicity seen in animal studies could also occur in humans
41
Table A.2.2 . Subchronic, Chronic and Other Toxicity Profile Guideline No. Study Type MRID No. (year)/ Classification /Doses Results 870.3050 28-Day Oral (rat)
ppm: 0 – 20 – 50 – 200 – 2000 – 20000 mg/kg/day: M: 0 – 1.53 – 3.88 – 15.1 – 152 – 1575 F: 0 – 1.63 – 4.17 – 16.1 – 156 – 1605 NOAEL (M/F) = 15.1 / 16.1 mg/kg/day LOAEL (M/F) = 152 /156 mg/kg/day based on: liver: ↑(m/f)– periportal fatty change, ↑wt [abs/rel (m/f)] ↓(f)– ALP ↑(f)– GPT
870.3050 28-Day Oral (mice)
ppm: 0 – 20 – 200 – 2000 – 20000 mg/kg/day: M: 0 – 2.73 – 26.9 – 265 – 2678 F: 0 – 2.88 – 30.0 – 299 – 3024 NOAEL (M/F) = 26.9 / 30.0 mg/kg/day LOAEL (M/F) = 265 / 299 mg/kg/day based on: liver: ↑(m/f)– hypertrophy (centrilobular hepatocytes);↑(m)– [dark-colored + fatty change (centrilobular hepatocytes)]
870.3050 28-Day Oral (dog)
ppm: 0 – 40 – 400 – 4,000 – 40,000 mg/kg/day: M: 0 – 1.12 – 10.7 – 101 – 1111 F: 0 – 1.10 – 12.0 – 120 – 1180 NOAEL (M/F) = 10.7 / 12.0 mg/kg/day LOAEL (M/F) = 101 / 120 mg/kg/day based on: ↑(m/f)– ALP
when there is a paucity of reliable data on the consequences of human exposure at levels approaching those with which JECFA is concerned.
to accumulate in the body.
period of time, JECFA has used the PTWI and PTMI.
TDI = Point of Departure (e.g.,NOAEL) Uncertainty Factors
determination of the NOAEL
Factor”
Chemical Specific Adjustment Factor(CASF)
KINETICS DYNAMICS KINETICS DYNAMICS
SPECIES DIFFERENCES HUMAN VARIABILITY
The use of uncertainty or safety factors
Uncertainty or safety factors are used to extrapolate from a group of test animals to an average human and from average humans to potentially sensitive sub-populations. Up to an additional 10x to protect children
10 10
Hazard identification Hazard characterization Exposure assessment Risk characterization
What will happen if you eat the food with the contaminant
data on the
chemical in the food
production
One such approach is the threshold of toxicological concern (TTC) concept.
contaminant
foods in question (high consumers)
levels.
provides (e.g. for average consumers and for high consumers),
integrating information from the hazard characterization and exposure assessment to produce scientific advice for Risk Managers.
does not necessarily imply that adverse health effects will occur in humans.
provides quantitative information from risk assessment for risk managers, enabling them to make decisions concerning the protection
❖Statements or evidence that the chemical is
❖A comparison of dietary exposures with health-based guidance values; ❖ Estimates of risks at different levels of dietary exposure; ❖Risks at minimum and maximum dietary intakes ❖Margins of exposure
Distinct from risk assessment, Weighs policy alternatives, in consultation with all interested parties, Consideris risk assessment and other factors relevant for the health protection of consumers and for the promotion of fair trade practices If needed, selecting appropriate prevention and control options
Interactive exchange of information and
concerning risk, risk-related factors and risk perceptions, among risk assessors, risk managers, consumers, industry, the academic community and other interested parties, including the explanation of risk assessment findings and the basis of risk management decisions.
trained experienced personnel)
sampling /availability reliable analytical method)
kanungo294@gmail.com